Actionable news
All posts from Actionable news
Actionable news in SRNE: Sorrento Therapeutics, Inc.,

The Institut Pasteur and Chan Soon-Shiong Institute for Molecular Medicine Partner to Form Global Genomics Center

PARIS & LOS ANGELES--(BUSINESS WIRE)--The Chan Soon-Shiong Institute for Molecular Medicine (CSSIOMM) and the Institut Pasteur today announced a partnership to establish The Pasteur Global Health Genomics Center (PGHGC). The aim of the PGHGC is to advance genomic research utilizing next-generation patient information systems needed to support the acquisition and usage of high-quality sequencing data.

“The creation of PGHGC will enable new approaches to therapeutic decisions, drug discovery capabilities, machine learning predictive modeling and support for clinical trials to evaluate the impact of therapeutic interventions in large patient populations”

Tweet this

Building on the strengths of the Institut Pasteur International Network, an existing network of National research Institutes, PGHGC will upgrade laboratory facilities on five continents to support the translation of data coming from intensive collaborative biomedical research into clinical practice. In addition, PGHGC will invest in data acquisition, education, basic research and training to fully deliver on the current promises of novel diagnostics and precision therapies in cancer and infectious diseases. The headquarters of the PGHGC will be located on the campuses of the Institut Pasteur, in Paris. PGHGC will have strong links with key science research centers within the Institut Pasteur International Network.

The Chan Soon-Shiong Institute has made an initial commitment of (US) $1 million to fund the design phase of the project, which includes advancing genomic research for precision medicine within the Institut Pasteur International Network. New resources will be dedicated to manage and coordinate the development of the genomics center in Paris. Simultaneously, an educational resource center in bioinformatics and data analysis will be created at the Institut Pasteur in Dakar; the facility will also lead to develop a “vaccine-pole” for the international network, with an expanded production center for vaccines and cellular based immunotherapies for cancer and infectious diseases research programs in West Africa.

A step-by-step process of accomplished milestones, including complementing resources by adjoining new high profile strategic partners, is anticipated to secure investments. Based on the milestones, six geographical sites for coverage in five continents will be added to PGHGC during 2017 and 2018. By 2020, a total of 12 global resource hubs for data intensive and high throughput based precision medicine will be fully operational, comprising the core of the PGHGC.

Today’s announcement in Paris was made jointly by the President of the Institut Pasteur, Dr. Christian Brechot and Dr. Patrick Soon-Shiong, the Chairman of the Chan-Soon-Shiong Family Foundation, and Chairman and CEO of the Chan-Soon-Shiong Institute of Molecular Medicine, a non-profit medical research organization.

Commenting on the announcement, Dr. Brechot said: “Recent ground-breaking developments in high throughput bio-technologies and computer science, together with accompanying breakthroughs in biochemistry and biophysics, have revolutionized the field of bio-medicine. To paraphrase Louis Pasteur, ‘We are now on the edge of solving mysteries in the 21st century, and more than at any other time in history...